Featured Articles
-
Getting CMC Right For Emerging Technologies
12/20/2023
Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.
-
Following The Science To Develop Best-In-Class Cancer Drugs
12/11/2023
As innovative cancer therapeutics continue to enter the clinical trial pipeline, some developers are shifting their focus toward developing drugs that are safe and efficacious with minimal toxicity.
-
A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments
12/11/2023
No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.
-
A Tale Of Two Brothers: The Abpro Founders
12/11/2023
By founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.
-
Welcoming The "Era Of ADCs"
12/5/2023
Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.
-
Longhorn's Path To A Universal Influenza Vaccine
12/2/2022
Thanks to the long-term planning of one biopharma family and some help from the U.S. Army, a universal influenza vaccine is coming soon to a clinical trial near you.
-
5 Translational Research Challenges On The Path To Patients
10/19/2022
As a translational researcher, you’re paving an uncharted path toward exciting new possibilities in healthcare. Explore five difficulties translational researchers face when developing a new therapy.
-
From Discovery To Commercial Promise With Philogen's Dr. Dario Neri
9/23/2022
In a recent episode of The Business of Biotech, Philogen CEO Dr. Dario Neri sat down to explore his journey from academia to startups, as well as Philogen's own trajectory.
-
Rethinking Cancer Treatment With Anixa's Amit Kumar
8/18/2022
Overcoming the hurdles of CAR-T therapy development for solid tumors will require novel science, innovative processing, and unshakeable optimism.
-
Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech
8/10/2022
Explore new, more agile approaches to overcoming the advanced therapy obstacles inherent to bringing rare disease treatments to market.